BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31694640)

  • 1. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis.
    Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Bai X; Sun B; Hung MC; Liu L; Wands J; Dong X
    Mol Cancer; 2019 Nov; 18(1):156. PubMed ID: 31694640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    Cancer Lett; 2020 Jul; 481():63-75. PubMed ID: 32145343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-organ metastasis as destination for breast cancer cells guided by biomechanical architecture.
    Lin Q; Chen X; Meng F; Ogawa K; Li M; Song R; Zhang S; Zhang Z; Kong X; Xu Q; He F; Liu D; Bai X; Sun B; Hung MC; Liu L; Wands JR; Dong X
    Am J Cancer Res; 2021; 11(6):2537-2567. PubMed ID: 34249415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cell-surface β-hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma.
    Aihara A; Huang CK; Olsen MJ; Lin Q; Chung W; Tang Q; Dong X; Wands JR
    Hepatology; 2014 Oct; 60(4):1302-13. PubMed ID: 24954865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Nagaoka K; Ogawa K; Ji C; Cao KY; Bai X; Mulla J; Cheng Z; Wands JR; Huang CK
    Dig Dis Sci; 2021 Apr; 66(4):1080-1089. PubMed ID: 32445050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartate β-hydroxylase modulates cellular senescence through glycogen synthase kinase 3β in hepatocellular carcinoma.
    Iwagami Y; Huang CK; Olsen MJ; Thomas JM; Jang G; Kim M; Lin Q; Carlson RI; Wagner CE; Dong X; Wands JR
    Hepatology; 2016 Apr; 63(4):1213-26. PubMed ID: 26683595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Relationship Between the Expression of Aspartate β-Hydroxylase and the Pathological Characteristics of Breast Cancer.
    Zhang Y; Gao Y; Li Y; Zhang X; Xie H
    Med Sci Monit; 2020 Dec; 26():e926752. PubMed ID: 33380715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate β-hydroxylase targeting in castration-resistant prostate cancer modulates the NOTCH/HIF1α/GSK3β crosstalk.
    Barboro P; Benelli R; Tosetti F; Costa D; Capaia M; Astigiano S; Venè R; Poggi A; Ferrari N
    Carcinogenesis; 2020 Sep; 41(9):1246-1252. PubMed ID: 32525968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis
    Zou Y; Lin J; Liu J; Zhang F; Yang T; Gong J; Jiang T; Zuo J; Song R; Shen H; Shen F; Li J
    Curr Protein Pept Sci; 2023; 24(5):436-446. PubMed ID: 37132101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway.
    Zou Q; Hou Y; Wang H; Wang K; Xing X; Xia Y; Wan X; Li J; Jiao B; Liu J; Huang A; Wu D; Xiang H; Pawlik TM; Wang H; Lau WY; Wang Y; Shen F
    EBioMedicine; 2018 May; 31():287-298. PubMed ID: 29764768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Human Aspartyl (Asparaginyl) β-hydroxylase in NSCLC: Its Diagnostic Value by Means of Exosomes of Bronchoalveolar Lavage.
    Zhu H; Liu H; Wen J; Yuan T; Ren G; Jiang Y; Yuan Y; Mei J; Yu Y; Li G
    Appl Immunohistochem Mol Morphol; 2021 Nov-Dec 01; 29(10):720-727. PubMed ID: 34433181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression.
    Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J
    PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INPP5F translocates into cytoplasm and interacts with ASPH to promote tumor growth in hepatocellular carcinoma.
    Zhou Q; Lin J; Yan Y; Meng S; Liao H; Chen R; He G; Zhu Y; He C; Mao K; Wang J; Zhang J; Zhou Z; Xiao Z
    J Exp Clin Cancer Res; 2022 Jan; 41(1):13. PubMed ID: 34996491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review).
    Zheng W; Wang X; Hu J; Bai B; Zhu H
    Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models.
    Mukherjee P; Zhou X; Galli S; Davidson B; Zhang L; Ahn J; Aljuhani R; Benicky J; Ailles L; Pomin VH; Olsen M; Goldman R
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of aspartate beta-hydroxylase in early breast cancer.
    Barboro P; Rubagotti A; Poddine S; Grillo F; Mastracci L; Boccardo F
    Int J Biol Markers; 2022 Sep; 37(3):328-335. PubMed ID: 35726161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update.
    Hou G; Xu B; Bi Y; Wu C; Ru B; Sun B; Bai X
    Bosn J Basic Med Sci; 2018 Nov; 18(4):297-304. PubMed ID: 30179586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspartate β-hydroxylase as a target for cancer therapy.
    Kanwal M; Smahel M; Olsen M; Smahelova J; Tachezy R
    J Exp Clin Cancer Res; 2020 Aug; 39(1):163. PubMed ID: 32811566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircTM7SF3 contributes to oxidized low-density lipoprotein-induced apoptosis, inflammation and oxidative stress through targeting miR-206/ASPH axis in atherosclerosis cell model in vitro.
    Wang X; Bai M
    BMC Cardiovasc Disord; 2021 Feb; 21(1):51. PubMed ID: 33526034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.